1 – 4 of 4
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Impact of add-back FSH on human and mouse prostate following gonadotropin ablation by GnRH antagonist treatment
(
- Contribution to journal › Article
- 2020
-
Mark
Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancer
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Testosterone suppression with a unique form of leuprorelin acetate as a solid biodegradable implant in patients with advanced prostate cancer : results from four trials and comparison with the traditional leuprorelin acetate microspheres formulation
(
- Contribution to journal › Article
- 2010
-
Mark
Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer
(
- Contribution to journal › Scientific review